Injectable Drug Delivery News
-
Kindeva Drug Delivery And Meridian Medical Technologies To Combine
11/15/2022
Kindeva Drug Delivery announced that it will combine with Meridian Medical Technologies. The combination will create a leading global drug-device combination product CDMO. Kindeva and Meridian will continue to operate independently until closing.
-
Bridgewest Group Inks Deal With Pfizer To Acquire Injectable Manufacturing Plant In Western Australia
11/11/2022
Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, is expanding its portfolio. Today, Bridgewest Group has announced the signing of a definitive agreement to purchase the sterile injectable manufacturing facility of Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc.
-
CMO Berkshire Sterile Manufacturing To Reveal New Isolator-Based Aseptic Filling Line November 16th
11/9/2022
Fill Finish CMO, Berkshire Sterile Manufacturing (BSM), will reveal its new, fully automated, 100% isolator-based filling line in a webinar on November 16th at 1PM EST.
-
Aptar Pharma Announces Collaboration With TFF Pharmaceuticals
11/7/2022
Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced a collaboration with TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform.
-
Stevanato Group And Gerresheimer AG Present EZ-Fill Smart, A New And Innovative Ready-To-Use Vial Platform
11/1/2022
Leveraging the established EZ-fill® market leading technology, process, and product optimization to improve quality, reduce total cost of ownership, and shorten lead times.
-
Terumo Pharmaceutical Solutions Expands CDMO Services Outside Japan For Global Market
10/31/2022
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.
-
Cingulate Announces Agreement With Societal CDMO And Provides Clinical Update
10/24/2022
Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has executed a Master Services Agreement (MSA) with Societal CDMO, Inc. (NASD: SCTL), a bi-coastal contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development.
-
INCOG BioPharma Primes Multi-Use Filling Line For Launch
10/19/2022
INCOG BioPharma Services, a contract development and manufacturing organization (CDMO), specializing in sterile injectables, has achieved another milestone by completing the installation of its state-of-the-art OPTIMA MultiUse production filling line at its Fishers headquarters.
-
Berkshire Sterile Provides A New Offering For Small Volume Filling
10/14/2022
Berkshire Sterile Manufacturing (BSM), a Massachusetts fill finish CMO, recently developed a new sterile filling process designed to reduce product loss for high-value drug product candidates. The process is intended for customers that have limited drug product and need to conserve every drop. It is additionally well suited for customers that have very small volume delivery needs with excellent precision. Filling is entirely isolator-based, easy to operate, and has demonstrated superior repeatability and accuracy.
-
Stevanato Group Collaborates With IL Group To Improve Safe Processing And Handling Of Hazardous Injectable Drugs
10/12/2022
The new integrated solution will leverage high-value solutions for drug containment (vials) and container protection (labels) to improve and facilitate the handling and storage of sensitive drugs, as well as ensure higher levels of safety for healthcare professionals and patients.